Zurcher Kantonalbank (Zurich Cantonalbank) - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 80 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$752,393
-24.6%
19,614
+15.5%
0.00%
-33.3%
Q1 2024$998,026
-17.1%
16,979
-15.6%
0.00%
-40.0%
Q4 2023$1,204,563
+125.8%
20,123
+43.5%
0.01%
+150.0%
Q3 2023$533,359
-53.9%
14,021
+10.3%
0.00%
-60.0%
Q2 2023$1,157,972
+50.6%
12,711
+9.0%
0.01%
+25.0%
Q1 2023$769,160
+39.9%
11,661
+9.6%
0.00%
+33.3%
Q4 2022$549,936
-30.0%
10,635
-7.6%
0.00%
-40.0%
Q3 2022$786,000
+66.9%
11,515
+10.6%
0.01%
+66.7%
Q2 2022$471,000
-20.3%
10,408
-10.5%
0.00%0.0%
Q1 2022$591,000
-8.5%
11,627
-14.9%
0.00%0.0%
Q4 2021$646,000
+168.0%
13,669
+86.8%
0.00%
+200.0%
Q3 2021$241,000
-47.8%
7,316
+0.2%
0.00%
-66.7%
Q2 2021$462,000
+49.0%
7,303
+1.1%
0.00%
+50.0%
Q1 2021$310,000
-33.3%
7,221
-11.1%
0.00%
-33.3%
Q4 2020$465,000
+89.8%
8,1260.0%0.00%
+50.0%
Q3 2020$245,000
-7.5%
8,1260.0%0.00%0.0%
Q2 2020$265,000
+108.7%
8,126
+71.4%
0.00%
+100.0%
Q1 2020$127,000
+2.4%
4,741
+17.3%
0.00%0.0%
Q4 2019$124,000
+117.5%
4,041
+69.5%
0.00%
Q3 2019$57,000
-24.0%
2,384
-19.0%
0.00%
-100.0%
Q2 2019$75,000
+108.3%
2,944
+59.6%
0.00%
Q1 2019$36,000
-5.3%
1,845
-36.4%
0.00%
Q4 2018$38,000
+90.0%
2,903
+159.7%
0.00%
Q3 2018$20,0001,1180.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders